Diabetes patients are at risk for severe SARS-CoV2 infection. Here, find new evidence-based guidance from an international panel, on how to manage these patients.
FDA Clears Omnipod 5 Algorithm Updates, Adding 100 mg/dL Target Glucose Option
Insulet enhances the Omnipod® 5 system with new glucose targets and algorithms, improving insulin delivery for diabetes management.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes
FDA approves Dexcom Smart Basal, a groundbreaking CGM-integrated insulin dosing optimizer, enhancing diabetes management for adults with Type 2 diabetes.
Respiratory Tripledemic 2022-23: An Expert Recap
William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.
Diabetes Self-Management at Work: A Checklist for Clinicians
Adults with diabetes often face obstacles to optimal disease management in the workplace. Use this checklist in the clinic to help them navigate the barriers.
The Hidden Toll of Diabetes in the Workplace: Global Survey Data
Global survey data highlight persistent stigma and self-management barriers for adults with diabetes in the workplace, with implications for clinical care.